Home 2017-07-10T12:07:17+00:00

We engage in the research, development, and commercialization of cell-based therapeutics for use in regenerative medicine.

Recent News

CESCA Therapeutics aquires the cell processing systems of Syngen under asset aquisition agreement Read More…

CESCA Therapeutics set to join russell microcap® index Read More…

CESCA Therapeutics to present at the 2017 marcum microcap conference Read More…

Our Vision

Cesca is a leader in the development and commercialization of automated blood and bone marrow processing systems that enable the separation, processing and preservation of cell and tissue therapy products.  The Company’s platform systems offer solutions for the delivery of autologous (obtained from the same individual) cell therapies that address significant unmet medical needs.  Cesca’s strategy is to partner with other pioneers in the stem cell arena to accelerate clinical evaluations, expedite regulatory approvals and penetrate the market.

ThermoGenesis - The device division of Cesca Therapeutics

ThermoGenesis, our device division, is a leading developer of automated technologies for clinical biobanking, point-of-care cell-based therapeutics and cellular processing for immuno-oncology and other clinical applications.
Learn More

Point of Care Treatments - the clinical division of Cesca Therapeutics

Cesca Clinical, our therapeutics division, leverages our proprietary cellular processing technology platform to develop safe and efficacious point-of-care therapies targeting a broad range of indications with unmet medical needs, including osteoarthritis and critical limb ischemia. Our goal is to establish partnerships to further advance these promising programs. Learn More

Boyalife is committed to innovative drug discovery, Precision Medicine technology, health management and disease model research. We are building an internationally influential life and health industry chain.